HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michele Fornaro Selected Research

agomelatine (S20098)

8/2017Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.
1/2015Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
6/2013The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.
1/2013Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study.
1/2013Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series.
2/2011Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series.
1/2011Agomelatine in the treatment of panic disorder.
9/2010A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michele Fornaro Research Topics

Disease

26Bipolar Disorder (Manic Depressive Psychosis)
01/2022 - 09/2010
25Major Depressive Disorder (Major Depressive Disorders)
02/2021 - 09/2010
24Schizophrenia (Dementia Praecox)
01/2022 - 03/2013
14Mania (Manias)
10/2021 - 01/2011
12Mental Disorders (Mental Disorder)
01/2022 - 09/2011
9Psychotic Disorders (Schizoaffective Disorder)
12/2021 - 12/2016
9Anxiety Disorders (Anxiety Disorder)
06/2021 - 09/2010
7Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
06/2021 - 12/2008
7Depressive Disorder (Melancholia)
03/2021 - 03/2013
6Mood Disorders (Mood Disorder)
01/2022 - 09/2010
5Treatment-Resistant Depressive Disorder
01/2020 - 01/2010
4Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2021 - 01/2015
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
06/2021 - 09/2010
3Inflammation (Inflammations)
12/2021 - 12/2016
3Neurobehavioral Manifestations
10/2021 - 03/2015
3Wounds and Injuries (Trauma)
09/2020 - 05/2012
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2010
3Alcoholism (Alcohol Abuse)
06/2016 - 01/2010
3Neuroblastoma
10/2014 - 10/2009
3Panic Disorder (Panic Attack)
02/2011 - 09/2010
2Cognitive Dysfunction
10/2021 - 03/2021
2Psychomotor Agitation (Akathisia)
03/2021 - 11/2019
2Treatment-Resistant Schizophrenia
02/2021 - 05/2018
2Nausea
06/2020 - 12/2010
2Sleep Initiation and Maintenance Disorders (Insomnia)
06/2020 - 01/2013
2Breast Neoplasms (Breast Cancer)
01/2020 - 01/2014
2Autism Spectrum Disorder
01/2020 - 12/2019
2Weight Loss (Weight Reduction)
10/2019 - 09/2011
2Pericarditis
11/2018 - 10/2014
2Catatonia
01/2018 - 03/2011
2Virus Diseases (Viral Diseases)
01/2018 - 01/2017
2Disease Susceptibility (Diathesis)
10/2010 - 01/2010
1Traumatic Brain Injuries (Traumatic Brain Injury)
02/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1COVID-19
11/2021

Drug/Important Bio-Agent (IBA)

26Antidepressive Agents (Antidepressants)IBA
03/2021 - 01/2010
17Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 08/2013
17Pharmaceutical PreparationsIBA
10/2021 - 10/2010
10Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
11/2021 - 12/2008
9Aripiprazole (Abilify)FDA Link
06/2021 - 12/2008
8Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2018
8agomelatine (S20098)IBA
08/2017 - 09/2010
6Biological ProductsIBA
10/2019 - 03/2013
5C-Reactive ProteinIBA
12/2021 - 01/2017
5Paliperidone PalmitateFDA Link
05/2021 - 08/2013
5Clozapine (Clozaril)FDA LinkGeneric
02/2021 - 10/2014
5Valproic Acid (Depakote)FDA LinkGeneric
06/2020 - 01/2013
5LithiumIBA
06/2020 - 01/2013
5Duloxetine Hydrochloride (Cymbalta)FDA Link
11/2013 - 01/2011
4MelatoninIBA
01/2022 - 09/2010
4Olanzapine (Zyprexa)FDA Link
06/2020 - 10/2010
3Risperidone (Risperdal Consta)FDA LinkGeneric
06/2021 - 08/2013
3Fluoxetine (Prozac)FDA LinkGeneric
06/2021 - 12/2010
3Methylphenidate (Ritalin)FDA LinkGeneric
06/2021 - 10/2019
3cariprazineIBA
02/2021 - 01/2016
3Neurotransmitter Agents (Neurotransmitter)IBA
03/2020 - 06/2010
3VortioxetineIBA
01/2020 - 01/2016
3Glutamic Acid (Glutamate)FDA Link
01/2019 - 03/2011
3Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2015 - 01/2011
2Oxytocin (Pitocin)FDA LinkGeneric
10/2021 - 03/2013
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2021 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
10/2021 - 01/2011
2AmphetaminesIBA
06/2021 - 10/2019
2Nerve Growth Factors (Neurotrophins)IBA
09/2020 - 09/2013
2Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
06/2020 - 01/2011
2Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
06/2020 - 10/2019
2Lurasidone HydrochlorideFDA Link
06/2020 - 01/2017
2EscitalopramFDA Link
06/2020 - 05/2014
2ziprasidone (Geodon)FDA Link
06/2020 - 01/2013
2HomocysteineIBA
03/2020 - 01/2019
2Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2020 - 05/2015
2LipidsIBA
03/2020 - 01/2017
2mesoglycanIBA
11/2018 - 01/2017
2Dopamine (Intropin)FDA LinkGeneric
01/2017 - 03/2011
2CytokinesIBA
01/2017 - 03/2013
23,4-methylenedioxyethamphetamine (MDEA)IBA
05/2015 - 01/2011
2Amyloid (Amyloid Fibrils)IBA
10/2012 - 01/2010
2Serotonin (5 Hydroxytryptamine)IBA
03/2011 - 01/2011
2Fluvoxamine (Luvox)FDA LinkGeneric
10/2010 - 01/2010
1ramelteon (Rozerem)FDA Link
01/2022
1Bupropion (Wellbutrin)FDA LinkGeneric
01/2022
1Varenicline (Chantix)FDA Link
01/2022
1Triglycerides (Triacylglycerol)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1KynurenineIBA
12/2021
1Tryptophan (L-Tryptophan)FDA Link
12/2021
1Trazodone (Trittico)FDA LinkGeneric
11/2021
1Investigational DrugsIBA
11/2021
1vabicaserinIBA
10/2021
1N-Methylaspartate (NMDA)IBA
10/2021
1ErythropoietinFDA Link
10/2021
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2021
1Cycloserine (Seromycin)FDA Link
10/2021
1Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2021
1Memantine (Namenda)FDA Link
10/2021

Therapy/Procedure

10Therapeutics
06/2021 - 09/2002
4Drug Therapy (Chemotherapy)
02/2022 - 02/2011
2Injections
05/2021 - 08/2013
2Aftercare (After-Treatment)
01/2020 - 08/2017
2Polypharmacy
11/2018 - 01/2016